1. Home
  2. ADIL vs IMTE Comparison

ADIL vs IMTE Comparison

Compare ADIL & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADIL
  • IMTE
  • Stock Information
  • Founded
  • ADIL 2010
  • IMTE 2008
  • Country
  • ADIL United States
  • IMTE Malaysia
  • Employees
  • ADIL N/A
  • IMTE N/A
  • Industry
  • ADIL Biotechnology: Pharmaceutical Preparations
  • IMTE Consumer Electronics/Appliances
  • Sector
  • ADIL Health Care
  • IMTE Consumer Staples
  • Exchange
  • ADIL Nasdaq
  • IMTE Nasdaq
  • Market Cap
  • ADIL 3.9M
  • IMTE 4.1M
  • IPO Year
  • ADIL 2018
  • IMTE N/A
  • Fundamental
  • Price
  • ADIL $0.34
  • IMTE $0.99
  • Analyst Decision
  • ADIL Strong Buy
  • IMTE
  • Analyst Count
  • ADIL 1
  • IMTE 0
  • Target Price
  • ADIL $8.00
  • IMTE N/A
  • AVG Volume (30 Days)
  • ADIL 22.2M
  • IMTE 10.6K
  • Earning Date
  • ADIL 08-12-2025
  • IMTE 07-07-2025
  • Dividend Yield
  • ADIL N/A
  • IMTE N/A
  • EPS Growth
  • ADIL N/A
  • IMTE N/A
  • EPS
  • ADIL N/A
  • IMTE N/A
  • Revenue
  • ADIL N/A
  • IMTE $123,337.00
  • Revenue This Year
  • ADIL N/A
  • IMTE N/A
  • Revenue Next Year
  • ADIL N/A
  • IMTE N/A
  • P/E Ratio
  • ADIL N/A
  • IMTE N/A
  • Revenue Growth
  • ADIL N/A
  • IMTE 4.75
  • 52 Week Low
  • ADIL $0.22
  • IMTE $0.51
  • 52 Week High
  • ADIL $3.00
  • IMTE $3.17
  • Technical
  • Relative Strength Index (RSI)
  • ADIL 50.21
  • IMTE 34.23
  • Support Level
  • ADIL $0.22
  • IMTE $0.87
  • Resistance Level
  • ADIL $0.27
  • IMTE $1.02
  • Average True Range (ATR)
  • ADIL 0.08
  • IMTE 0.05
  • MACD
  • ADIL -0.01
  • IMTE -0.01
  • Stochastic Oscillator
  • ADIL 53.15
  • IMTE 41.93

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.

About IMTE Integrated Media Technology Limited

Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.

Share on Social Networks: